Business Segments · Goodwill, transfer to held-for-sale
Oncology & Multispecialty — Goodwill, transfer to held-for-sale
McKesson Oncology & Multispecialty — Goodwill, transfer to held-for-sale remained flat by 0.0% to $2.25M in Q1 2026 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ4 2026May 8, 2026
Rolls up toGoodwill written off on sale of business
How to read this metric
An increase signals a strategic shift or divestment, potentially reducing future operational complexity but also reducing future earnings contribution.
Detailed definition
The carrying value of goodwill associated with a business unit or asset group that has been classified as held for sale....
Peer comparison
Standard accounting disclosure for discontinued operations or assets held for sale.
Metric ID:
mck_segment_oncology_multispecialty_goodwill_transfer_to_held_for_saleHistorical Data
2 years
| FY'25 | FY'26 | |
|---|---|---|
| Value | $0.00 | $9.00M |
Range$0.00 – $9.00M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — goodwill, transfer to held-for-sale?
- McKesson (MCK) reported oncology & multispecialty — goodwill, transfer to held-for-sale of $2.25M in Q1 2026.
- What does oncology & multispecialty — goodwill, transfer to held-for-sale mean?
- The value of goodwill assigned to business assets currently being sold.